EXHIBIT 10.2Registration Rights Agreement • June 4th, 2001 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • New York
RECITALSPurchase Agreement • April 11th, 2002 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
EXHIBIT HStock Purchase Agreement • April 11th, 2002 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
EXHIBIT 10.34 LYNX THERAPEUTICS, INC. LOAN AND SECURITY AGREEMENT This LOAN AND SECURITY AGREEMENT is entered into as of October 23, 2002, by and between COMERICA BANK-CALIFORNIA ("Bank") and LYNX THERAPEUTICS, INC. ("Borrower").Loan and Security Agreement • November 13th, 2002 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
ARTICLE I DEFINITIONSSecurities Purchase Agreement • January 2nd, 2004 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • New York
RECITALSMerger Agreement • March 27th, 1997 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • Delaware
ARTICLE.1 PURCHASE AND SALE OF ASSETS........................ 5 ARTICLE.2 CLOSING AND PURCHASE PRICE......................... 6 ARTICLE.3 REPRESENTATIONS AND WARRANTIES OF THE SELLER....... 8 ARTICLE.4 REPRESENTATIONS AND WARRANTIES OF...Asset Purchase Agreement • April 6th, 2004 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products
CONFIDENTIAL SERVICES AGREEMENT This SERVICES AGREEMENT ("Agreement") is made and entered into as of [*] 2003 ("Effective Date"), by and between E.I. du Pont de Nemours and Company, having a principal business address at 1007 Market Street,...Services Agreement • November 13th, 2003 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
EXHIBIT 10.32 VIA COURIER July 9, 2002 Dr. Norrie Russell 60 Hillmont Place Danville, CA 94526 Dear Norrie: This letter sets forth the substance of the separation agreement (the "Agreement") which Lynx Therapeutics, Inc. (the "Company") is offering to...Separation Agreement • August 14th, 2002 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT is made by and between LYNX THERAPEUTICS, INC., a Delaware corporation (the "Company"), and Edward C. Albini ("Purchaser"). WITNESSETH: WHEREAS, Purchaser holds one stock option to purchase shares...Stock Purchase Agreement • March 30th, 1998 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
PART 4 SUBLEASE AND EMPLOYEESAcquisition Agreement • March 24th, 1998 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
EXHIBIT 10.35 COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • March 28th, 2003 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
EMPLOYEE AGREEMENT FOR KEVIN P. CORCORANEmployment Agreement • August 14th, 2002 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
ARTICLE I DEFINITIONSSecurities Purchase Agreement • March 12th, 2004 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • New York
TEXT OMITTED AND FILED SEPARATELY CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTIONS 200.80(B)(4) AND 240.24B-2 FIRST AMENDMENT TO JOINT VENTURE AGREEMENT between Lynx Therapeutics Inc., 25861 Industrial Boulevard, Hayward, California, 94545,...Joint Venture Agreement • November 13th, 2001 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products
ARTICLE II REPRESENTATIONS AND WARRANTIESSecurities Purchase Agreement • June 4th, 2001 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • New York
1 EXHIBIT 10.3 NEITHER THESE SECURITIES NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM...Securities Agreement • June 4th, 2001 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products
NET LEASE BASIC LEASE INFORMATIONLease Agreement • May 13th, 1998 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
RECITALSPurchase Agreement • March 15th, 2002 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
RECITALSSecurities Purchase Agreement • April 30th, 2002 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • Virginia
BETWEENCollaboration Agreement • September 21st, 2001 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
RECITALSIntellectual Property Security Agreement • January 3rd, 2005 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
ARTICLE.1 PURCHASE AND SALE OF ASSETS................................. 5 ARTICLE.2 CLOSING AND PURCHASE PRICE.................................. 6 ARTICLE.3 REPRESENTATIONS AND WARRANTIES OF THE SELLER................ 8 ARTICLE.4 REPRESENTATIONS AND...Asset Purchase Agreement • May 13th, 2004 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products
EMPLOYEE AGREEMENT FOR THOMAS J. VASICEK, PH.D.Employment Agreement • August 14th, 2002 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
EMPLOYEE AGREEMENT FOR KATHY A. SAN ROMANEmployment Agreement • May 15th, 2003 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
EXHIBIT 10.53 LOAN AND SECURITY AGREEMENT THIS LOAN AND SECURITY AGREEMENT (this "Agreement") dated as of December 28, 2004, between SILICON VALLEY BANK, a California chartered bank, with its principal place of business at 3003 Tasman Drive, Santa...Loan and Security Agreement • January 3rd, 2005 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • Delaware
AGREEMENTRegistration Rights Agreement • April 30th, 2002 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • Virginia
Exhibit 8.2 [Heller Ehrman White & McAuliffe LLP Letterhead] Solexa Limited c/o Abingworth Management Ltd. 3000 Sand Hill Road Bldg. 4, Suite 135 Menlo Park, California 94025 Ladies and Gentlemen: This opinion is being delivered to you in connection...Acquisition Agreement • January 5th, 2005 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products
Exhibit 8.2 [Heller Ehrman White & McAuliffe LLP Letterhead] January 21, 2005 Solexa Limited c/o Abingworth Management Ltd. 3000 Sand Hill Road Bldg. 4, Suite 135 Menlo Park, California 94025 Ladies and Gentlemen: This opinion is being delivered to...Acquisition Agreement • January 21st, 2005 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products
RECITALSLoan Agreement • October 29th, 2004 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
EXHIBIT 10.13 RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • August 24th, 2001 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
EXHIBIT 10.55 WARRANT TO PURCHASE STOCK THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF...Warrant to Purchase Stock • January 3rd, 2005 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
INDEMNITY AGREEMENTIndemnification Agreement • November 13th, 2006 • Solexa, Inc. • Medicinal chemicals & botanical products • Delaware
THIS AGREEMENT is made and entered into as of the 9th day of November, 2006 by and between SOLEXA, INC., a Delaware corporation (the “Corporation”), and ANTHONY SMITH (the “Agent”).
Solexa, Inc. Stock Option Agreement (Incentive Stock Option or Nonstatutory Stock Option)Stock Option Agreement • June 9th, 2005 • Solexa, Inc. • Medicinal chemicals & botanical products
Pursuant to your Stock Option Grant Notice (“Grant Notice”) and this Stock Option Agreement, Solexa, Inc. (the “Company”) has granted you an option under its 2005 Equity Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Stock Option Agreement but defined in the Plan shall have the same definitions as in the Plan.
RECITALSTechnology Development and Services Agreement • May 15th, 2002 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
